Claritas Rx Appoints New CFO and Head of Marketing

Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announced new leadership appointments designed to continue growth and scale. The company has welcomed Kevin Donalds as Chief Financial Officer (CFO) and Elizabeth Marshall as Head of Marketing. Both will report directly to Michael Fitzgibbons, Claritas Rx’s CEO.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250521974207/en/

Kevin Donalds joins Claritas Rx as Chief Financial Officer.

Mr. Donalds has been the CFO at several highly successful B2B SaaS companies including Granular, Tutor.com and Popkin Software. He also held Finance leadership roles at Priceline and META Group. He started his career in public accounting at Deloitte. Kevin holds a BS in accounting from the University of Rhode Island and a CPA.

Ms. Marshall comes to Claritas Rx with significant Marketing and Communications experience at high-growth companies. She held Marketing leadership positions at Trinity Life Sciences, IDEMIA and Decision Resource Group (DRG). She holds a BS from the Newhouse School of Public Communications at Syracuse University and an MBA from Boston University.

“I’m delighted to welcome both Kevin and Liz to our Claritas Rx Executive Team,” said Michael Fitzgibbons. “As we continue to scale, their background and expertise will help us not only manage long-term growth initiatives that are beneficial to our clients, but also the internal change management that is critical to a fast-growing company.”

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx is a technology company focused on managing real world data focused on specialty biopharmaceutical distribution channels in oncology and rare/orphan diseases. Since 2011, the company has illuminated brand performance and the patient journey for dozens of therapies. Claritas Rx creates actionable business intelligence that helps manufacturers more effectively go to market and enhance the patient experience. For more information, visit www.claritasrx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250521974207/en/

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.